Pharmaceutical Executive
October 25, 2006
0
0
Merck's Januvia has a head start, but Novartis isn't sitting idle.
October 25, 2006
0
0
Emerging countries are expected to drive pharma's earnings next year.
October 25, 2006
0
0
After winning a bidding war for Pliva, the well-positioned generic maker is giving pharma reason to worry.